42 results on '"Lee, Namsu"'
Search Results
2. Bloodless Treatment of Jehovah’s Witness Patients with Lymphoma and Multiple Myeloma
3. Development of an 360-degree virtual reality video-based immersive cycle training system for physical enhancement in older adults: a feasibility study: Development of immersive virtual cycle for older adults
4. PB2207: NEUTROPHIL–TO-LYMPHOCYTE RATIO IS AN EARLY SCREENING TOOL FOR DIAGNOSIS OF POLYCYTHEMIA VERA
5. Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as new possible minor criteria for diagnosis of polycythemia vera.
6. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)
7. The Effects of Iron Deficiency on the Gut Microbiota in Women of Childbearing Age
8. A Retrospective Analysis of Bone Marrow Examination Results from a Single Center Institution: In What Situations Is Bone Marrow Examination Helpful?
9. Neutrophil-to-Lymphocyte Ratio Is More Accurate Than Erythropoietin Level for the Polycythemia Vera Diagnosis
10. The Effects of Iron Deficiency on the Gut Microbiota in Young Women
11. Neutrophil–lymphocyte ratio and carotid plaque burden in patients with essential thrombocythemia and polycythemia vera
12. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide
13. Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
14. Eosinophilia in Patients with End Stage Renal Disease Undergoing Hemodialysis
15. Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience
16. Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
17. Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
18. Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review
19. Posaconazole versus Itraconazole as Prophylactic Antifungal Agents during Induction Chemotherapy for Acute Myeloid Leukemia: A Real-World Single Center Comparison
20. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents
21. Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer
22. A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
23. Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer.
24. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
25. Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell
26. Abstract 3843: Pulmonary toxicities of molecular targeted antineoplastic agents
27. Abstract 3844: Venous thromboembolism in patients with pancreatic cancer
28. A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer.
29. Venous Thromboembolism (VTE) In Patients With Pancreatic Cancer
30. Src Family Kinase Inhibitor PP2 Enhances Differentiation Of Acute Promyelocytic Leukemia Cell Line Induced By Combination Of ATRA and Arsenic Trioxide
31. Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line
32. Association between c-Met and lymphangiogenic factors in patients with colorectal cancer.
33. Angiogenic marker associated with resistance to neoadjuvant chemoradiotherapy in rectal cancer.
34. Onion and pizza
35. Src Family Kinase Inhibitor PP2 Has Different Effects On ATRA or Arsenic Trioxide-Induced Differentiation of Acute Promyelocytic Leukemia Cell Line
36. Antiemetic effectiveness of palonosetron and first-generation serotonin inhibitors for high emetic risk chemotherapy in the post-aprepitant era.
37. Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer.
38. Oral chemotherapeutic agents in current use
39. Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.
40. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
41. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer [corrected]
42. Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.